Ellevest, Inc. Enanta Pharmaceuticals Inc Transaction History

Ellevest, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$48.29 - $71.27 $8,257 - $12,187	-171 Reduced 68.4%	79 $4,000
Q2 2022 Jul 18, 2022	BUY	$38.13 - $76.93 $2,821 - $5,692	74 Added 42.05%	250 $12,000
Q1 2022 Apr 19, 2022	SELL	$56.06 - $74.11 $1,793 - $2,371	-32 Reduced 15.38%	176 $13,000
Q4 2021 Jan 24, 2022	SELL	$60.19 - $97.37 $1,745 - $2,823	-29 Reduced 12.24%	208 $16,000
Q3 2021 Oct 19, 2021	SELL	$41.02 - $58.65 $5,250 - $7,507	-128 Reduced 35.07%	237 $13,000
Q2 2021 Jul 13, 2021	BUY	$43.76 - $53.11 $1,969 - $2,389	45 Added 14.06%	365 $16,000
Q1 2021 May 03, 2021	BUY	$41.69 - $54.95 $4,002 - $5,275	96 Added 42.86%	320 $16,000
Q4 2020 Feb 04, 2021	BUY	$41.16 - $47.47 $6,832 - $7,880	166 Added 286.21%	224 $9,000
Q3 2020 Oct 26, 2020	BUY	$43.36 - $53.53 $86 - $107	2 Added 3.57%	58 $3,000
Q1 2020 Apr 13, 2020	BUY	$40.22 - $62.0 $2,252 - $3,472	56 New	56 $3,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.